These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 19723083
1. Tumor necrosis factor inhibitors block apoptosis of human epithelial cells of the salivary glands. Sisto M, D'Amore M, Caprio S, Mitolo V, Scagliusi P, Lisi S. Ann N Y Acad Sci; 2009 Aug; 1171():407-14. PubMed ID: 19723083 [Abstract] [Full Text] [Related]
2. Targeting TNF-α suppresses the production of MMP-9 in human salivary gland cells. Aota K, Azuma M. Arch Oral Biol; 2013 Dec; 58(12):1761-8. PubMed ID: 24200302 [Abstract] [Full Text] [Related]
3. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies. Sisto M, Lisi S, Lofrumento DD, Frassanito MA, Cucci L, D'Amore S, Mitolo V, D'Amore M. Int Immunol; 2009 Dec; 21(12):1341-9. PubMed ID: 19854762 [Abstract] [Full Text] [Related]
4. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies. Sisto M, Lisi S, Lofrumento DD, Caprio S, Mitolo V, D'Amore M. Immunobiology; 2010 Nov; 215(11):874-83. PubMed ID: 20061048 [Abstract] [Full Text] [Related]
5. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages. Atreya R, Zimmer M, Bartsch B, Waldner MJ, Atreya I, Neumann H, Hildner K, Hoffman A, Kiesslich R, Rink AD, Rau TT, Rose-John S, Kessler H, Schmidt J, Neurath MF. Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498 [Abstract] [Full Text] [Related]
8. Activation of the extrinsic apoptotic pathway by TNF-alpha in human salivary gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and intercellular adhesion molecule-1 (ICAM-1) in Sjögren's syndrome-associated autoimmune sialadenitis. Wang Y, Shnyra A, Africa C, Warholic C, McArthur C. Arch Oral Biol; 2009 Nov; 54(11):986-96. PubMed ID: 19716548 [Abstract] [Full Text] [Related]
9. Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner. Vos AC, Wildenberg ME, Duijvestein M, Verhaar AP, van den Brink GR, Hommes DW. Gastroenterology; 2011 Jan; 140(1):221-30. PubMed ID: 20955706 [Abstract] [Full Text] [Related]
10. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB. Mohan RR, Mohan RR, Kim WJ, Wilson SE. Invest Ophthalmol Vis Sci; 2000 May; 41(6):1327-36. PubMed ID: 10798647 [Abstract] [Full Text] [Related]
11. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Kaymakcalan Z, Sakorafas P, Bose S, Scesney S, Xiong L, Hanzatian DK, Salfeld J, Sasso EH. Clin Immunol; 2009 May; 131(2):308-16. PubMed ID: 19188093 [Abstract] [Full Text] [Related]
12. Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept. Shen C, Assche GV, Colpaert S, Maerten P, Geboes K, Rutgeerts P, Ceuppens JL. Aliment Pharmacol Ther; 2005 Feb 01; 21(3):251-8. PubMed ID: 15691299 [Abstract] [Full Text] [Related]
13. Effects of biological drug adalimumab on tumour necrosis factor-alpha-converting enzyme activation. Lisi S, Sisto M. Immunol Cell Biol; 2010 Feb 01; 88(3):297-304. PubMed ID: 19949420 [Abstract] [Full Text] [Related]
14. Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis. Lisi S, Sisto M, Lofrumento DD, Cucci L, Frassanito MA, Mitolo V, D'Amore M. J Autoimmun; 2010 Sep 01; 35(2):160-70. PubMed ID: 20673622 [Abstract] [Full Text] [Related]
17. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Centorrino T, Siriwardena AK, Cuzzocrea S. Shock; 2007 May 01; 27(5):542-51. PubMed ID: 17438460 [Abstract] [Full Text] [Related]
20. Anti-Ro/SSA antibodies are an independent factor associated with an insufficient response to tumor necrosis factor inhibitors in patients with rheumatoid arthritis. Matsudaira R, Tamura N, Sekiya F, Ogasawara M, Yamanaka K, Takasaki Y. J Rheumatol; 2011 Nov 01; 38(11):2346-54. PubMed ID: 21965648 [Abstract] [Full Text] [Related] Page: [Next] [New Search]